Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 18, 2018 - The FDA approved an update to the Warnings and Precautions sections of the Neupogen (filgrastim) and Neulasta (pegfilgrastim) drug labels regarding aortitis.
Return to publications